🇺🇸 FDA
Patent

US 8658627

Pregnancy hormone combination for treatment of autoimmune diseases

granted A61KA61K31/56A61K31/565

Quick answer

US patent 8658627 (Pregnancy hormone combination for treatment of autoimmune diseases) held by The Regents of the University of California expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/56, A61K31/565, A61K31/57, A61K31/785